Actos Bladder Cancer Lawsuit

Our attorneys are looking at cases of bladder cancer that may be linked to Acotos, a Type-2 diabetes drug. The U.S. Food and Drug Administration (FDA) has issued a warning that use of Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.

The FDA warning was based on the FDA's review of data from a planned five-year interim analysis of an ongoing, ten-year epidemiological study.¹ The five-year results showed that although there was no overall increased risk of bladder cancer with pioglitazone use, an increased risk of bladder cancer was noted among patients with the longest exposure to pioglitazone, and in those exposed to the highest cumulative dose of pioglitazone.

FDA is also aware of a recent epidemiological study conducted in France which suggests an increased risk of bladder cancer with pioglitazone. Based on the results of this study, France has suspended the use of pioglitazone and Germany has recommended not to start pioglitazone in new patients.

Additional facts about Actos and pioglitazone:

The maker of Actos is Takeda Pharmaceuticals North America, Inc.
Pioglitazone is sold as a single-ingredient product under the brand-name Actos. It is also sold in combination with metformin (Actoplus Met, Actoplus Met XR) and glimepiride (Duetact).
Used along with diet and exercise to improve control of blood sugar in adults with type 2 diabetes mellitus.
From January 2010 through October 2010, approximately 2.3 million patients filled a prescription for a pioglitazone-containing product from outpatient retail pharmacies.2

Free Consultation:
Our Law Firm Does Not Get Paid Unless You Win

To contact the firm about an Actos bladder cancer suit against Takeda, please call toll-free at 1-888-377-8900 or submit the firm's free consultation form. Because there are time limitations for filing lawsuits, please contact our law firm as soon as possible:

Call 1-888-377-8900 (toll-free)
Contact our law firm about a free consultation regarding an Actos lawsuit

References:

Lewis JD, Ferrara A, PengHedderson M, Bilker WB, QuesenberryJr, et al. Diabetes Care. 2011;34:916-22.
SDI, Vector One®: Total Patient Tracker (TPT). January 2010-October 2010. Data extracted 12-15-10.

States: Alabama AL, Arkansas AK, Arizona AZ, Arkansas AR, California CA, Colorado CO, Connecticut CT, Delaware DL, District of Columbia DC, Florida FL, Georgia GA, Idaho ID, Illinois IL, Indiana IN, Iowa IA, Kansas KS, Kentucky KY, Louisiana LA, Maine ME, Maryland MD, Massachusetts MA, Michigan MI, Minnesota MN, Mississippi MS, Missouri MO, Montana MT, Nebraska NE, New Hampshire NH, New Jersey NJ, New York NY, North Carolina NC, North Dakota ND, Ohio OH, Oklahoma OK, Pennsylvania PA, Rhode Island RI, South Carolina SC, South Dakota SD, Tennessee TN, Texas TX, Vermont VT, Virginia VA, Washington WA, West Virginia WV, Wisconsin WI, and Wyoming WY.

Free Case Consultation

We are Not Paid Unless You Win

Our attorneys work on a continguency fee basis, meaning you do not have to pay our law firm for representing you unless we win you money.

Firm News

AV Preeminent Rating by Martindale-Hubbell

Attorneys Fred Pritzker and Eric Hageman have been given the highest rating by Martindale-Hubbell for attorney, AV Preeminent. An AV® certification mark is a significant rating accomplishment - a testament to the fact that a lawyer's peers rank him or her at the highest level of professional excellence.

Adjunct Teaching Position At U of M Law School

Attorney Brendan Flaherty has accepted an adjunct teaching position at the University of Minnesota Law School. For the 2011 spring semester, Flaherty will teach a course entitled "Practice and Professionalism," which will introduce students to foundational lawyering skills and professional responsibility issues.

Attorney Elliot Olsen Speaks at Conference

Attorney Elliot Olsen recently spoke at the Seventh Annual LifeScience Alley Conference in Minneapolis on Preemption and the Future of Medical Device Litigation. He appeared with Randall Pattee of Lindquist and Vennum and Jean Lance, VP of corporate legal and general counsel for Boston Scientific.

Named Super Lawyer

In recognition of their achievements, Attorneys Fred Pritzker, Elliot Olsen and Eric Hageman were named "Super Lawyers" by Law & Politics magazine. According to Super Lawyers, "The objective is to create a credible, comprehensive and diverse listing of outstanding attorneys that can be used as a resource to assist attorneys and consumers in the search for legal counsel."

Brendan Flaherty Named a Rising Star

In recognition of his achievements, Attorney Brendan Flaherty was named a 2010 Rising Star by Minnesota Law & Politics. Only 2.5 percent of the state’s lawyers are included on the list, which highlights Minnesota’s best up-and-coming legal talent.

Fred Pritzker Listed in The Best Lawyers in America

Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.

This is attorney advertising. Past results do not guarantee a similar outcome. The result of each case is determined by the specific facts and the applicable law.

Practice Areas

Other Practice Areas

Personal Injury and Wrongful Death